Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-07

Clinical Trial Update: Impact of Strattera and Behavior Therapy on the Home and School Functioning of Children With ADHD [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the impact of Strattera (atomoxetine) and behavior therapy on home and school functioning in children with ADHD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • STRATTERA (Atomoxetine hydrochloride)

Snippet

Sponsor: State University of New York at Buffalo | Conditions: Attention Deficit Hyperactivity Disorder | Phase 4 | Status: COMPLETED | Results posted: 2020-04-07